» Authors » Asha Anand

Asha Anand

Explore the profile of Asha Anand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 157
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Madabhavi I, Modi G, Panchal H, Patel A, Revannasiddaiah S, Anand A, et al.
Int J Hematol Oncol Stem Cell Res . 2018 Jan; 11(4):296-300. PMID: 29340126
Peripheral T cell lymphomas are a heterogeneous group of post-thymic, mature lymphoid malignancies, accounting for approximately 10-15% of all non-Hodgkin's lymphomas. Hepatosplenic T-cell lymphoma (HSGDTCL) is a rare entity, which...
22.
Satyarth S, Parikh S, Anand A, Sawhney J, Panchal H, Patel A, et al.
Indian J Med Paediatr Oncol . 2017 Dec; 38(3):354-356. PMID: 29200689
The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which...
23.
Kalaskar P, Anand A, Panchal H, Patel A, Parikh S, Shah S
South Asian J Cancer . 2017 Oct; 6(3):132-133. PMID: 28975124
Introduction: The treatment of acute myeloid leukemia (AML) consists of induction therapy with anthracyclines and cytarabine followed by two to four cycles of consolidation therapy with high-dose cytarabine after achieving...
24.
Chirmade P, Parikh S, Anand A, Panchal H, Patel A, Shah S
Adv Respir Med . 2017 Sep; 85(4):206-210. PMID: 28871588
Primary lung neoplasms are rare in children. The most common primary lung malignancies in children are pleuropulmonary blastoma and carcinoid tumour. Synovial sarcoma (SS) accounts for approximately 1% of all...
25.
Madabhavi I, Modi G, Patel A, Anand A, Panchal H, Parikh S
J Cancer Res Ther . 2017 Sep; 13(3):466-470. PMID: 28862210
Background: Bleomycin-induced pulmonary (BIP) toxicity is a notorious entity and cropped up in roughly 10% of cases. The aim of the study is to evaluate BIP at our tertiary care...
26.
Madabhavi I, Patel A, Sarkar M, Anand A, Panchal H, Parikh S
Clin Med Insights Oncol . 2017 May; 11:1179554917691031. PMID: 28469510
Background: Effective and reliable venous access is one of the cornerstones of modern medical therapy in oncology. Materials And Methods: This is a prospective observational study, which collected data of...
27.
Modi G, Madabhavi I, Patel A, Anand A, Panchal H, Parikh S, et al.
J Obstet Gynaecol India . 2016 Nov; 66(Suppl 2):690-693. PMID: 27803546
No abstract available.
28.
Madabhavi I, Patel A, Anand A, Panchal H, Parikh S
Clin Respir J . 2016 Sep; 12(2):806-810. PMID: 27606884
About 4% of non-small-cell lung carcinomas involve an EML4-ALK tyrosine kinase fusion gene and occur almost absolutely in carcinomas arising in non-smokers. Crizotinib, the first inhibitor of anaplastic lymphoma kinase...
29.
Raut S, Shah S, Shah K, Patel K, Talati S, Parikh S, et al.
Indian J Hematol Blood Transfus . 2016 Jul; 32(3):284-91. PMID: 27429520
Total 26 children of thalassemia underwent hematopoetic stem cell transplantation from September 2006 to December 2014. Out of these 17 were matched sibling transplantation (MST) and 9 were unrelated umbilical...
30.
Joshi K, Panchal H, Parikh S, Modi G, Talele A, Anand A, et al.
Indian J Hematol Blood Transfus . 2016 Jul; 32(Suppl 1):46-9. PMID: 27408353
The author describes paediatric case of relapsed acute lymphoblastic leukaemia (ALL) presented as aleukemic leukaemia cutis (ALC). A 2 year old child was admitted in tertiary oncology centre. He suffered...